I have drawn a lot of comfort from knowledge I gained at past evenings attending Harvard Science in the News (SITN) program, where doctoral candidates describe what they're working on in ways that the public can understand.
Here is an article I am reading from the science in the news blog:
http://sitn.hms.harvard.edu/flash/2017/cancer-immunotherapy-fighting-fire-fire/
Some readers know that Matt Cam'n is in a clinical trial where CAR-T is being tested on his hard lung tumor. The article above links to this one on why that poses an extra challenge for immune therapy.(hard tumors are big, have relatively poor surface area, and create a local environment hostile to immune cells (t-cells).
http://www.genengnews.com/gen-articles/supplement-treating-solid-tumors-with-car-t-cells/5912
Subscribe to:
Post Comments (Atom)
Day 1 of Ibrutinib
I took my first pill of ibrutinib today at 7am. The pill "wallet" (individual pills in individual "blisters" on a 4-we...
-
At around 10am on Monday, they'll put me in a Fluoroscope,* a kind of fuzzy-but-live-action X-ray so that they can snake a Central Ven...
-
Before the next round of chemo I hope to have implanted one of these "ports" under the skin of either my chest or upper arm: I...
-
Mrs Blogger was joined by Bloggette #3 (12 yrs old) for a midday visit. Bloggette Three is something of an old hospital pro, having had her...
1 comment:
These Nordic people seem to be out front of some of this. http://www.bloodjournal.org/content/112/7/2687.full?sso-checked=true
Post a Comment